EphA2 Antibody (N-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Other Accession | P41240 |
---|
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP7701a was selected from the N-term region of human EphA2 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
---|---|
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
EphA2, which belongs to the Tyr family of protein kinases, is a receptor for members of the ephrin-A family. It binds to ephrin-A1, -A3, -A4 and -A5. This protein may interact with SLA It is a Type I membrane protein expressed most highly in tissues that contain a high proportion of epithelial cells, e.g., skin, intestine, lung, and ovary. The structure contains putative domains for 2 fibronectin type III and 1 sterile alpha motifs (SAM).
References
Lindberg, R.A., et al., Mol. Cell. Biol. 10(12):6316-6324 (1990).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.